Gastroenterology Briefs: Biological Aging Tied to Colon Cancer, Other Findings
A Korean cohort linked faster biological aging to higher risks of early-onset colorectal and colon adenocarcinoma. Other briefs covered a pancreatic cancer risk algorithm for type 2 diabetes, possible hepatitis B transmission from domestic cats, an investigational hepatitis C regimen, and new cirrhosis preventive-care guidance. The roundup also noted research on food-related IBD symptoms and liver-protective effects of certain antihypertensives in MASLD.
In a large Korean group, faster biological aging tracked with 93% greater odds of early-onset colorectal adenocarcinoma and 132% greater odds of early-onset colon adenocarcinoma. An algorithm built from routinely gathered clinical measures may help gauge pancreatic cancer risk among people with type 2 diabetes, according to a China-based study.
Briefs also noted a possible small risk that domestic cats could transmit hepatitis B; a phase II hepatitis C trial in which eight weeks of bemnifosbuvir plus ruzasvir yielded 90% virologic response at 12 weeks; and fresh American College of Gastroenterology guidance for cirrhosis prevention. Research further examined why IBD patients react to foods they once tolerated and whether certain blood-pressure drugs protect the liver in MASLD.
These findings could affect patients with early-onset colorectal cancer risk, type 2 diabetes, chronic hepatitis, cirrhosis, MASLD, and IBD, along with their clinicians. If validated, biological-aging markers and routine-data algorithms may help identify people who might benefit from earlier discussions or closer monitoring. New hepatitis and cirrhosis guidance could shape preventive care, while food-trigger and antihypertensive findings may prompt further research. The societal impact may depend on access, implementation, and whether these signals translate into better outcomes.